Biodexa Pharmaceuticals (BDRX) Change in Receivables (2013 - 2021)
Biodexa Pharmaceuticals (BDRX) reported Change in Receivables of -$1.2 million for Q3 2021, down 92.26% on a YoY basis from -$15.4 million in Q3 2020, and down 83.35% sequentially from -$650982.3 in Q4 2020.
Biodexa Pharmaceuticals (BDRX) Change in Receivables (2013 - 2021) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 6 years of Change in Receivables data on file, last reported at -$1.2 million in Q3 2021.
- For the quarter ending Q3 2021, Change in Receivables fell 92.26% year-over-year to -$1.2 million; the trailing twelve-month figure through Sep 2021 stood at -$2.4 million (up 24.94% YoY), and the FY2025 full-year result was $3.5 million, up 145.2% from the prior year.
- Change in Receivables fell to -$1.2 million in Q3 2021, from -$650982.3 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $78429.2 in Q4 2019 to a low of -$1.2 million in Q3 2021.
- A 3-year average of -$596736.5 and a median of -$635903.8 in 2020 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables tumbled 930.03% in 2020 and tumbled 92.26% in 2021, its largest moves.
- Tracing BDRX's Change in Receivables over 3 years: stood at $78429.2 in 2019, then plunged by 930.03% to -$650982.3 in 2020, then plunged by 83.35% to -$1.2 million in 2021.
- Business Quant data shows BDRX's Change in Receivables at -$1.2 million in Q3 2021, -$650982.3 in Q4 2020, and -$620825.2 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 17, 2021 | -1.19 Mn |
| Sep 17, 2021 | -1.19 Mn |
| Dec 31, 2020 | -650,982.34 |
| Dec 31, 2020 | -650,982.34 |
| Sep 10, 2020 | -620,825.22 |
| Sep 10, 2020 | -620,825.22 |
| Dec 31, 2019 | 78,429.22 |
| Dec 31, 2019 | 78,429.22 |
| Dec 31, 2016 | -300,859.79 |
| Dec 31, 2016 | -300,859.79 |
| Dec 31, 2015 | -2.34 Mn |
| Dec 31, 2015 | -2.34 Mn |
| Dec 31, 2013 | -715,630.38 |
| Dec 31, 2013 | -715,630.38 |